Delivery Order SPE2DB22D1106-SPE2DB24FEDG5
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $11,085.06 contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, in support of military treatment programs and facilities. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to...
- This is a $45,665.78 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, with a period of performance through November 1, 2024. AmerisourceBergen holds a broader $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract valued at $13,901.54 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, with a potential value of $2,770.74 and a completion date of February 13, 2024. The contract does not have any set-aside designation....
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $20,014.44 order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical product. This delivery order is placed under an indefinite delivery contract (IDC) previously awarded to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, with a ceiling value of $11,082.96 and a performance period through April 5, 2024. This award is associated with a larger...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, to support military treatment programs and facilities. The delivery order has a ceiling value of $27,757.07 and a completion date of March 1, 2022....
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,916.62 order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, to support military treatment programs and facilities. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued up...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS, with a ceiling value of $5,615.96 and a period of performance through April 5, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, providing a wide range of pharmaceutical products and medical supplies to U.S. government...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $74,297.32, is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication. The contract has an ultimate completion date of January 23, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEDG5Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, to support military treatment programs and facilities. The contract has a total potential value of $10,480.01 and a period of performance through March 6, 2024. This award is not associated with any set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, as well as on a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 3/5/24 |